CEACAM5 and bladder transitional cell carcinoma: In this study, the relationship between CEA immunostaining and clinicopathological parameters of disease progression as well as patient outcome was analysed in more than 2700 urothelial bladder carcinomas in a tissue microarray (TMA) format.